Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation - van Esser, J W; Niesters, H G; van der Holt, B (Blood, 2002)
, et al.